Boulder Care, the nation’s fastest-growing value-based addiction medicine provider, today announced the appointment of Marianna Zaslavsky as Vice President of Growth Partnerships.

Boulder Care, a leading provider of telehealth-based addiction treatment, is proud to announce a new agreement with Cone Health to expand access to critical care for individuals living with opioid and alcohol use disorders in North Carolina. The collaboration will bring Boulder’s telehealth model of care—grounded in respect, compassion, and long-term support—to individuals in Greensboro and beyond, ensuring that people living with substance use disorders have access to the care they need, when they need it.

A new white paper delves into the experience of Peer Recovery Specialists at Boulder. Peers speak the language of recovery and foster connection with patients through shared experience. Peers are integral to our virtual care model.

The White House declared this week Overdose Awareness Week, boasting $22 billion of new investment to address the overdose crisis – including massive investments in “expanding access to life-saving medications.”

It’s an honor for Boulder’s growth to be recognized by Inc. Here is how we got here, why our growth matters, and what it means for the future.

The New York Times this week reported a ~3% annual decline in national overdose deaths, and asked, “Has fentanyl peaked?” It hasn’t — and we’ve made this mistaken assumption before, with irrevocable consequences. Here’s what we know:

Recently, journalists have targeted Portland, OR as the exemplar for an emergent debate: as the addiction crisis rages on, are policies that decriminalize low-level drug crimes helping or hurting?

The disparities faced by the LGBTQ+ community in addiction treatment demand our attention. Understanding the specific challenges and consequences is crucial for promoting inclusivity and improving outcomes. It is our collective responsibility in the medical field to address these disparities through increased support, research, and advocacy.

I’ve been a nurse in Ohio for three decades and, for the past ten years, I’ve been focused on Opioid Use Disorder patients. I have never seen a more effective model than the collaborative, whole-patient approach at Boulder Care.

Telehealth treatment for opioid addiction is working. Pandemic flexibilities helped Americans access life-saving medications like buprenorphine without increasing misuse. So why are we going backward? The DEA’s newly proposed “guardrails” are more aptly “roadblocks” for addiction patients and providers alike.

The DEA announced a proposal for new rules for prescribing controlled substances - including buprenorphine - that could impact telehealth patients and add a single in-person requirement. Boulder is prepared to help patients navigate this change and fight back to make treatment easy and accessible.

The COVID-era PHE made SUD care accessible in a profound new way. But that could all change once the PHE expires. Boulder has been preparing to ensure continuity of care for our current and future patients and is actively advocating for better regulations to help all people in need of addiction care.

Ben MacLean, Boulder's General Counsel, explains how laws and regulations can fight against patients with SUDs and stand in the way of better treatment options.

Boulder's in-house writer, Michael, who also works in TV and film, explains how Hollywood's obsession with sad stories has created a distorted view of patients with substance use disorder.